This product is an ASHP Learning Center https://elearning.ashp.org/ activity.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
The Specialty Pharmacy: Inflammatory and Neurologic Disease States Certificate is self-guided, with online learning activities that have been created for pharmacists seeking to expand their skills in specialty pharmacy management of inflammatory and neurologic disease states.
Overview
The Specialty Pharmacy Certificate is self-guided, with online learning activities that have been created for pharmacists seeking to expand their skills in specialty pharmacy.
A learner begins with the Specialty Pharmacy Fundamentals, where the well-rounded curriculum gives the essential information on business models and operations of specialty pharmacies, patient management, specialty pharmacy accreditations, structuring outcomes to determine value within a specialty pharmacy, and common specialty pharmacy disease state overviews. To move to the next step, the learner will need to pass the comprehensive assessment for the Fundamentals section.
Please note: Once a learner has completed and passed the Fundamentals section, they are not required to retake it if they wish to enroll in additional disease state tracks.
As part of their bundle, once a learner passes the Fundamentals section, they will take a deep dive into their selected specialty focus with the Inflammatory and Neurologic Disease States Track.These topics include dermatology, gastroenterology, rheumatology, and neurology.
Specialty Pharmacy: Inflammatory and Neurologic Disease States Professional Certificate Requirement
Once a learner has completed the Specialty Pharmacy Fundamentals and Inflammatory and Neurologic Disease States Track educational curriculum, they will have the opportunity to complete the track’s final exam. Once the learner successfully completes the track’s final exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the Specialty Pharmacy: Inflammatory and Neurologic Disease States Professional Certificate.
Educational Activities
Specialty Pharmacy Fundamentals
Specialty Pharmacy 101
ACPE: 0204-0000-25-847-H04-P
Application-based
1 contact hour
Learning Objectives:
- Explain key specialty pharmacy terms and abbreviations.
- Compare stakeholder priorities in specialty pharmacy.
- Summarize key elements in the landscape of specialty pharmacy.
Specialty Pharmacy Organizational Models and Program Designs
ACPE: 0204-0000-25-848-H04-P
Application-based
1.25 contact hours
Learning Objectives:
- Explain the three types of procurement models for sourcing medications administered in a health care setting (white/brown/clear bagging).
- Apply the appropriate billing method(s) for specialty medications.
- Identify differences among four different specialty pharmacy organizational structures.
- Develop a new specialty pharmacy business plan.
- Identify considerations for developing a specialty pharmacy program.
Specialty Pharmacy Patient Management
ACPE: 0204-0000-25-849-H04-P
Application-based
1.25 contact hours
Learning Objectives:
- Explain specialty pharmacy documentation requirements.
- Discuss the tenets of specialty medication monitoring.
- Describe multidisciplinary collaborative opportunities in specialty pharmacy.
- Apply specialty medication patient education and counseling principles.
- Assess specialty medication adherence.
- Describe medication error and adverse event reporting methods.
Introduction to Specialty Pharmacy Medications
ACPE: 0204-0000-25-850-H04-P
Application-based
1 contact hour
Learning Objectives:
- Contrast generic medications with biosimilar products.
- Explain the elements of safe medication handling and disposal.
- Evaluate strategies for drug access.
Operations: The Backbone of Specialty Pharmacy
ACPE: 0204-0000-25-851-H04-P
Application-based
1 contact hour
Learning Objectives:
- Differentiate the roles of specialty pharmacy staff from retail and hospital pharmacy staff.
- Explain the main steps of the specialty pharmacy supply chain.
- Predict potential challenges associated with specialty medication delivery.
From Prescription to Patient: A Specialty Medication's Journey
ACPE: 0204-0000-25-852-H04-P
Application-based
1 contact hour
Learning Objectives:
- Define the important elements of a specialty prescription.
- Analyze potential issues associated with ordering a specialty medication.
- Describe a specialty medication benefits investigation and prior authorization.
- Assess specialty prescription dispensing factors.
- Summarize the specialty prescription verification process.
- Differentiate specialty prescription delivery requirements and methods.
From Diagnosis to Treatment: The Journey for Patients with Specialty Conditions
ACPE: 0204-0000-25-853-H04-P
Application-based
0.75 contact hour
Learning Objectives:
- Summarize financial assistance options for patients with specialty conditions and serving the underserved.
- Differentiate between manufacturer-provided and pharmacy-provided patient education resources.
- Interpret patient satisfaction results.
Specialty Pharmacy Accreditation and Certifications
ACPE: 0204-0000-25-854-H04-P
Application-based
0.75 contact hour
Learning Objectives:
- Define specialty pharmacy accreditation.
- Assess the importance and benefits of specialty pharmacy accreditation.
- Categorize the different specialty pharmacy accreditations available.
- Differentiate between various pharmacist and pharmacy technician certifications.
Outcomes and Value of Specialty Pharmacy
ACPE: 0204-0000-25-855-H04-P
Application-based
2.5 contact hours
Learning Objectives:
- Describe the need and methods to collect, track, and report disease-specific outcomes in specialty pharmacy practice.
- Select clinical performance outcomes measures to collect, based on key institution, patient, disease state, and stakeholder requirement factors.
- Design quality improvement initiatives to advance outcomes monitoring and response.
- Measure the clinical and economic impact of specialty pharmacy staff actions.
- Assess how the hub-and-spoke information dissemination model promotes the value of specialty pharmacy.
- Apply operational and financial metrics to assess specialty pharmacy performance.
- Critique specialty pharmacy performance based on a scorecard.
Common Specialty Pharmacy Service Lines
ACPE: 0204-0000-25-856-H04-P
Application-based
2 contact hours
Learning Objectives:
- Summarize the basics of inflammatory diseases.
- Summarize the basics of oncology and hematology.
- Summarize the basics of neurology.
- Summarize the basics of human immunodeficiency virus (HIV) and hepatitis.
- Summarize the basics of cystic fibrosis.
- Summarize the basics of hemophilia and PAH.
Inflammatory Conditions: The Basics
ACPE: 0204-0000-25-872-H01-P
Application-based
1 contact hour
Learning Objectives:
- Categorize the management versus curative goals of therapy for inflammatory disease states.
- Summarize historical and current treatment advances for inflammatory disease states treatments.
- Assess additional clinical considerations for inflammatory disease states.
Dermatology
ACPE: 0204-0000-25-873-H01-P
Application-based
2 contact hours
Learning Objectives:
- Differentiate dermatologic disease states treated with specialty medications.
- Categorize on-label versus off-label dermatologic conditions and drug therapies.
- Interpret dermatologic tools used for diagnosis.
- Evaluate vaccination requirements and recommendations.
- Summarize non-pharmacologic, non-specialty, and specialty therapies used to treat chronic dermatology conditions.
- Identify a specialty pharmacist’s impact on this patient population.
Gastroenterology
ACPE: 0204-0000-25-874-H01-P
Application-based
2 contact hours
Learning Objectives:
- Describe the prevalence and clinical presentation of inflammatory bowel disease (IBD), including subjective and objective diagnostic factors.
- Identify acute and long-term complications of IBD as well as risk factors for the development of long-term complications, including short gut syndrome.
- Recommend preventative care, nonpharmacologic, non-specialty, and/or infused treatments for patients with IBD.
- Select appropriate lab work to be ordered both prior to initiating and to monitor safety and efficacy of biologic and small molecule treatments.
- Counsel patients on the mechanism of action, dosing, administration, and common adverse drug events (ADRs) for currently available FDA-approved pharmacologic agents for IBD.
- Recommend pharmacologic regimens for patients with moderately-severely active IBD.
- Develop a therapeutic plan for patients with treatment failure, incomplete response, or loss of response to current pharmacologic regimen.
Rheumatology
ACPE: 0204-0000-25-875-H01-P
Application-based
2.25 contact hours
Learning Objectives:
- Differentiate rheumatologic disease states treated with specialty medications.
- Summarize the impact of overlapping diseases.
- Interpret rheumatologic tools used for diagnosis and scoring.
- Evaluate vaccination requirements and recommendations.
- Summarize non-pharmacologic, non-specialty, infusion, and specialty therapies used to treat chronic rheumatologic conditions.
- Identify a specialty pharmacist’s impact on this patient population.
Neurology
ACPE: 0204-0000-25-876-H01-P
Application-based
2.25 contact hours
Learning Objectives:
- Describe the prevalence, clinical presentation, and pathophysiology of multiple sclerosis (MS), including subjective and objective diagnostic factors.
- Counsel patients on the mechanism of action, dosing, administration, and common adverse drug events (ADRs) for currently available FDA-approved pharmacologic agents for MS.
- Develop a therapeutic plan for treatment of MS in patients starting biologic treatments as well as in patients with treatment failure or intolerance to a current pharmacologic regimen.
- Recommend preventative care, nonpharmacologic treatments, non-specialty, and/or infused treatments for patients with neurologic disorders.
- Describe the prevalence, clinical presentation, and etiology of movement disorders such as Huntington’s disease, Parkinson’s disease, tardive dyskinesia, and spinal muscle atrophy (SMA), including subjective and objective diagnostic factors.
- Counsel patients on the mechanism of action, dosing, administration, and common adverse drug events (ADRs) for currently available FDA-approved pharmacologic agents for movement disorders.
- Recommend preventative care, nonpharmacologic treatments, non-specialty, and/or infused treatments for patients with neurologic disorders.
Faculty Information
Stefanie Cisek, PharmD, BCACP
Clinical Pharmacist
Northwestern Medicine
Chicago, Illinois
Dana Harman, PharmD, MBA, CSP
Specialty Pharmacy Manager
University of Missouri Health Care
Columbia, Missouri
Daniel Madrid, PharmD, MBA
Site Director, Sinai Chicago
Clearway Health
Chicago, Illinois
Bernice Man, PharmD, MBA, BCSP, CPHQ, CSP, DPLA
Clinical Pharmacy Manager
University of Chicago Medicine
Chicago, Illinois
Ashley Nixon-Mongler, PharmD, BCACP
Clinical Pharmacist
University of Missouri Health Care
Columbia, Missouri
Christine Pan, PharmD, BCACP
Clinical Pharmacist
Northwestern Medicine
Chicago, Illinois
Marci Saknini, PharmD, CSP
Clinical Pharmacist Specialist
Vanderbilt Specialty Pharmacy
Nashville, Tennessee
Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP
Director, Health Outcomes and Research
Vanderbilt University Medical Center
Nashville, Tennessee
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
- Stephanie Cisek: Boehringer Ingelheim, Speaker’s Bureau; Fresenius Kabi, Speaker's Bureau
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.
Methods and CE Requirements
Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
The ASHP Professional Certificates SM educational product line contains learning activities that are ACPE-accredited knowledge and application-based continuing education. This is not an ACPE Certificate Program. Upon successful completion of the activities, the learner will be able to download an ASHP Professional Certificate.
System Technical Requirements
ASHP learning content is delivered through your Web browser. For all learning content, you will need basic computer skills, the ability to navigate web pages and stable internet connection. View the system requirements for learning activities.